The Inhalation
Anesthesia Market Insights by Product
(Sevoflurane, Isoflurane, Desflurane), Application (Induction, Maintenance) and
Region - Global Forecast till 2030
The Inhalation Anesthesia
Market size is expected to reach USD 1.5 Billion by 2032 at 8.3% CAGR during
the forecast period 2023-2032.
The global inhalation anesthesia market is
mainly driven by the increasing number of surgical procedures being conducted
around the world and was valued at USD 1.12 billion in 2018. The market is
profiled in detail in the report, which includes detailed historical profiles
of the major factors affecting the market’s growth trajectory. Major drivers
and restraints affecting the inhalation anesthesia market are profiled in the
report. Key players operating in the inhalation anesthesia market are also
profiled in the report to give readers a clear idea of the competitive dynamics
in the market.
Inhalation anesthesia is a process of
delivering anesthesia via inhalation rather than injection. Inhalation
anesthesia is widely used for inducing as well as maintaining sedation in
patients undergoing surgical procedures. Maintaining sedation is the primary
application of inhalation anesthesia rather than inducing it, as the dosage and
effect of inhalation anesthesia can be judged more accurately than injected
anesthesia. The increasing demand for minimally invasive or noninvasive
procedures in the healthcare sector is likely to be a major driver for the
inhalation anesthesia market over the forecast period. Rather than being
injected into the body, inhalation anesthesia materials are administered by
inhalation, allowing painless administration of anesthesia. This has helped the
inhalation general anesthesia market achieve steady growth in recent years and
is likely to remain a major driver for the market in the coming years.
The increasing demand for surgical procedures is likely to be a major driver
for the inhalation anesthesia market over the forecast period. The increasing
geriatric population around the world is likely to be a key factor driving up
the demand for surgeries, as the geriatric population is more likely to require
surgeries than younger demographics. The increasing prevalence of cancer,
cardiovascular conditions, and neurological conditions is also likely to drive
up the demand for surgical procedures in the coming years, thus acting as a significant
growth driver for the inhalation anesthesia market.
Competitive
Analysis:
Leading players in the inhalation
anesthesia market include AbbVie Inc., Fresenius Kabi AG, Jiangsu Hengrui
Medicine Co. Ltd., Piramal Enterprises Ltd., Lunan Pharmaceutical Group Co.
Ltd., Hikima Pharmaceuticals plc, Halocarbon Products Corporation, and Baxter
International Inc. Leading players in the global inhalation anesthesia market
are likely to focus on the development of more effective anesthesia products in
the coming years. Eliminating the risk of side effects and maximizing the
potency of the anesthesia agent is likely to be a key objective for inhalation
anesthesia market players over the forecast period.
Segmentation:
The global inhalation anesthesia market trends is segmented on the basis of
product type, application, and region.
By product, the global inhalation
anesthesia market is segmented into sevoflurane, isoflurane, and desflurane.
By application, the global inhalation
anesthesia market is segmented into induction and maintenance.
Regional Analysis:
The report covers the Americas, Europe,
Asia Pacific, and MEA (Middle East and Africa) regional markets to provide a
comprehensive breakdown of the inhalation anesthesia market’s presence in each
region. The Americas are likely to remain the dominant force in the global
inhalation anesthesia market over the forecast period, with North America
dominating the global charts for production as well as usage of inhalation
anesthetics. The Americas region held a share of close to 50% in the global
inhalation anesthesia market in 2018 and is likely to remain a major regional
market for inhalation anesthesia in the coming years. Widespread presence of
advanced healthcare infrastructure and awareness about inhalation anesthetics
are the major drivers for the inhalation anesthesia market in North America.
Europe accounts for the second largest
share in the global inhalation anesthesia market, holding around 30% of the
global market. Strong development in healthcare research is likely to be a
major driver for the inhalation anesthesia market in the region over the
forecast period.
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1 628
258 0071
Email:
sales@marketresearchfuture.com
0 Comments